These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14639034)

  • 1. Acute myocardial infarction following intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy in association with a monoclonal immunoglobulin G paraprotein.
    Stamboulis E; Theodorou V; Kilidireas K; Apostolou T
    Eur Neurol; 2004; 51(1):51. PubMed ID: 14639034
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
    Comi G; Quattrini A; Fazio R; Roveri L
    Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin, blood viscosity and myocardial infarction.
    Fisman DN; Smilovitch M
    Can J Cardiol; 1997 Aug; 13(8):775-7. PubMed ID: 9284845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin therapy in the inflammatory neuropathies.
    Churchyard A; Day T; Grainger K; Mastaglia FL
    Clin Exp Neurol; 1991; 28():168-79. PubMed ID: 1821824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Cornblath DR; Chaudhry V; Griffin JW
    Ann Neurol; 1991 Jul; 30(1):104-6. PubMed ID: 1929221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?
    Alexandrescu DT; Dutcher JP; Hughes JT; Kaplan J; Wiernik PH
    Am J Hematol; 2005 Mar; 78(3):216-20. PubMed ID: 15726606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
    Lopate G; Choksi R; Pestronk A
    Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin treatment in three children with chronic inflammatory demyelinating neuropathy.
    Hergüner MO; Incecik F; Altunbaşak S
    Pediatr Neurol; 2009 Sep; 41(3):223-5. PubMed ID: 19664543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis associated with high dose intravenous gammaglobulin.
    Craig TJ; Davis W
    Ann Allergy; 1993 Sep; 71(3):276. PubMed ID: 8373001
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome.
    Engel WK
    Acta Myol; 2003 Dec; 22(3):97-103. PubMed ID: 15088499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A syndrome of chronic ataxic polyneuropathy, ophtalmoplegia, IgM paraprotein, cold agglutinins and anti-disialosyl antibodies can cause diplopia in patients with chronic sensory polyneuropathy].
    Kolmos EB; Moth Henriksen M; Abildgaard N; Sindrup SH
    Ugeskr Laeger; 2012 Oct; 174(43):2635-6. PubMed ID: 23095653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy: a prospective study of efficacy, safety and tolerability.
    Cats EA; van der Pol WL; Piepers S; Notermans NC; van den Berg-Vos RM; van den Berg LH
    J Neurol; 2008 Oct; 255(10):1598-9. PubMed ID: 18758888
    [No Abstract]   [Full Text] [Related]  

  • 14. [High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy].
    Tomiyama M; Baba M; Matsunaga M; Takada H; Okushima T; Narita S; Takebe K
    No To Shinkei; 1992 Nov; 44(11):979-82. PubMed ID: 1296721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic inflammatory demyelinating polyneuropathy: multifocal demyelinating neuropathy].
    Baba M; Matsunaga M
    No To Shinkei; 1992 Aug; 44(8):709-18. PubMed ID: 1419348
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-associated polyneuropathy syndromes: principles and treatment.
    Kornberg AJ; Pestronk A
    Semin Neurol; 2003 Jun; 23(2):181-90. PubMed ID: 12894383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives].
    Léger JM; Chassande B
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammatory demyelinating polyneuropathy.
    Smith H; Salam I; Findley LJ
    J R Army Med Corps; 1994 Jun; 140(2):90-2. PubMed ID: 8907837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.